News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Verastem, Inc. (VSTM) Reports Year-End 2013 Financial Results



3/6/2014 7:22:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Verastem, Inc., (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the year ended December 31, 2013, and also commented on corporate accomplishments and plans.

"In 2013, Verastem achieved critical milestones in our mission to bring new therapies targeting cancer stem cells to patients," said Robert Forrester, President and Chief Executive Officer of Verastem.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES